In CX3CR1+ monocytes among ITP patients, the protein expression level of NLRP3 was up‐regulated, which was further suppressed in BMDM after the DAC treatment in ITP mice model (Figure 6B). The gene discussed is NLRP3; the disease is autoimmune thrombocytopenic purpura.